PMC:4621299 / 18806-19291 JSONTXT

{"project":"TEST0","denotations":[{"id":"26578865-230-238-323932","span":{"begin":470,"end":474},"obj":"[\"21549339\"]"}],"text":"As stated above, the cis-Golgi SNARE GS27 (GOSR2) binds to α-synuclein and is part of a SNARE complex that is destabilized by mutant α-synuclein. GS27 has also been shown to be associated with a neurological disorder in humans. Six patient were identified baring a mutation that results in improper subcellular localization and loss of function of GS27 leading to symptoms common in COG-CDG patients such as cerebral atrophy, epilepsy, and early ataxia (Corbett et al., 2011; Table 1)."}

{"project":"0_colil","denotations":[{"id":"26578865-21549339-323932","span":{"begin":470,"end":474},"obj":"21549339"}],"text":"As stated above, the cis-Golgi SNARE GS27 (GOSR2) binds to α-synuclein and is part of a SNARE complex that is destabilized by mutant α-synuclein. GS27 has also been shown to be associated with a neurological disorder in humans. Six patient were identified baring a mutation that results in improper subcellular localization and loss of function of GS27 leading to symptoms common in COG-CDG patients such as cerebral atrophy, epilepsy, and early ataxia (Corbett et al., 2011; Table 1)."}

{"project":"2_test","denotations":[{"id":"26578865-21549339-38257413","span":{"begin":470,"end":474},"obj":"21549339"}],"text":"As stated above, the cis-Golgi SNARE GS27 (GOSR2) binds to α-synuclein and is part of a SNARE complex that is destabilized by mutant α-synuclein. GS27 has also been shown to be associated with a neurological disorder in humans. Six patient were identified baring a mutation that results in improper subcellular localization and loss of function of GS27 leading to symptoms common in COG-CDG patients such as cerebral atrophy, epilepsy, and early ataxia (Corbett et al., 2011; Table 1)."}